• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于鼻腔和肺部抗原及DNA递送的可生物降解的粘膜粘附微粒。

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.

作者信息

Alpar H Oya, Somavarapu S, Atuah K N, Bramwell V W

机构信息

University of London, School of Pharmacy, 29-39 Brunswick Square, Bloomsbury, London, WC1N 1AX, UK.

出版信息

Adv Drug Deliv Rev. 2005 Jan 10;57(3):411-30. doi: 10.1016/j.addr.2004.09.004.

DOI:10.1016/j.addr.2004.09.004
PMID:15560949
Abstract

Biodegradable polymer and particulate carriers have been shown to be of considerable potential for the delivery of peptides, proteins and DNA in animal models. In the context of vaccine delivery to the upper and lower respiratory tracts, the use of mucoadhesive agents offers a strategy for the facilitation of increased residence time and increased vaccine efficacy. Additional concerns addressed here include the potential of uptake of vaccine formulations by the primary olfactory nerves in the nasal cavity, effective delivery to the lung, strategies to maximise the immunopotentiation of candidate vaccine formulations, as well as the evaluation of animal models and interpretation of engendered immune responses in terms of antigen-specific antibody production. Experimental data are presented that demonstrate the potential of muco- and bioadhesive agents in combination with liposomes for intranasal (i.n.) delivery of tetanus toxoid in mice. A delivery system utilising chitosan for the formulation of microspheres by the spray-drying method is described and assessed for intranasal vaccine delivery, and porous particles with potential for pulmonary administration are also outlined.

摘要

在动物模型中,可生物降解的聚合物和微粒载体已显示出在递送肽、蛋白质和DNA方面具有相当大的潜力。在上、下呼吸道疫苗递送的背景下,使用粘膜粘附剂提供了一种增加停留时间和提高疫苗效力的策略。这里讨论的其他问题包括鼻腔中初级嗅觉神经摄取疫苗制剂的可能性、有效递送至肺部、使候选疫苗制剂的免疫增强最大化的策略,以及动物模型的评估和根据抗原特异性抗体产生对所引发的免疫反应的解释。本文给出了实验数据,证明了粘膜和生物粘附剂与脂质体联合用于小鼠鼻内递送破伤风类毒素的潜力。描述并评估了一种利用壳聚糖通过喷雾干燥法制备微球用于鼻内疫苗递送的递送系统,还概述了具有肺部给药潜力的多孔颗粒。

相似文献

1
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.用于鼻腔和肺部抗原及DNA递送的可生物降解的粘膜粘附微粒。
Adv Drug Deliv Rev. 2005 Jan 10;57(3):411-30. doi: 10.1016/j.addr.2004.09.004.
2
Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.用于非侵入性疫苗递送的单-N-羧甲基壳聚糖(MCC)和N-三甲基壳聚糖(TMC)纳米颗粒。
Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9.
3
Nasal vaccine innovation.鼻腔疫苗创新。
J Drug Target. 2010 Dec;18(10):771-86. doi: 10.3109/1061186X.2010.523790.
4
The application of mucoadhesive polymers in nasal drug delivery.黏膜黏附聚合物在鼻腔给药中的应用。
Drug Dev Ind Pharm. 2010 Mar;36(3):323-36. doi: 10.1080/03639040903170750.
5
Liposomes as delivery systems for nasal vaccination: strategies and outcomes.脂质体作为鼻腔疫苗传递系统:策略和结果。
Expert Opin Drug Deliv. 2010 Jul;7(7):829-44. doi: 10.1517/17425247.2010.488687.
6
Nasal delivery of vaccines.疫苗的鼻腔给药。
J Drug Target. 1996;3(6):455-67. doi: 10.3109/10611869609015965.
7
Surface modified liposomes for nasal delivery of DNA vaccine.用于DNA疫苗鼻腔递送的表面修饰脂质体。
Vaccine. 2008 Apr 24;26(18):2225-33. doi: 10.1016/j.vaccine.2008.02.058. Epub 2008 Mar 17.
8
Nanoparticles as carriers for nasal vaccine delivery.纳米颗粒作为鼻腔疫苗递送载体
Expert Rev Vaccines. 2005 Apr;4(2):185-96. doi: 10.1586/14760584.4.2.185.
9
Low molecular weight chitosan in DNA vaccine delivery via mucosa.低分子量壳聚糖在经黏膜递送DNA疫苗中的应用
Int J Pharm. 2009 Jun 22;375(1-2):123-32. doi: 10.1016/j.ijpharm.2009.03.032. Epub 2009 Apr 5.
10
Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.新型疫苗制剂的需求以及颗粒抗原和DNA递送系统的潜力。
Adv Drug Deliv Rev. 2005 Jan 10;57(3):325-31. doi: 10.1016/j.addr.2004.10.001.

引用本文的文献

1
Self-assembling TLR2 agonists promote mucosal immune responses without pulmonary immunopathologic injuries in mice.自组装Toll样受体2(TLR2)激动剂可促进小鼠黏膜免疫反应,且不会造成肺部免疫病理损伤。
NPJ Vaccines. 2025 Jun 18;10(1):127. doi: 10.1038/s41541-025-01185-y.
2
Pulmonary Delivery of Nonviral Nucleic Acid-Based Vaccines With Spotlight on Gold Nanoparticles.以金纳米颗粒为重点的非病毒核酸疫苗的肺部递送
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb;17(1):e70000. doi: 10.1002/wnan.70000.
3
Lipid-Based Nanoparticles as Oral Drug Delivery Systems: Overcoming Poor Gastrointestinal Absorption and Enhancing Bioavailability of Peptide and Protein Therapeutics.
基于脂质的纳米颗粒作为口服给药系统:克服胃肠道吸收不良并提高肽和蛋白质治疗药物的生物利用度。
Adv Pharm Bull. 2024 Mar;14(1):48-66. doi: 10.34172/apb.2024.016. Epub 2023 Oct 14.
4
Evaluation of Biodegradable Microparticles for Mucosal Vaccination Against Diphtheria Toxoid: Nasal Efficacy Studies in Guinea Pigs.用于白喉类毒素黏膜疫苗接种的可生物降解微粒的评估:豚鼠鼻腔给药效果研究
Turk J Pharm Sci. 2023 Nov 7;20(5):294-301. doi: 10.4274/tjps.galenos.2022.05626.
5
Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment.纳米颗粒:新冠病毒预防、诊断与治疗的一项突破。
Arch Med Sci. 2021 Oct 15;19(5):1410-1420. doi: 10.5114/aoms/142103. eCollection 2023.
6
Recent progress in application of nanovaccines for enhancing mucosal immune responses.纳米疫苗在增强黏膜免疫反应应用方面的最新进展。
Acta Pharm Sin B. 2023 Jun;13(6):2334-2345. doi: 10.1016/j.apsb.2022.08.010. Epub 2022 Aug 21.
7
An evolving perspective on novel modified release drug delivery systems for inhalational therapy.对新型改良型吸入治疗药物释放系统的不断发展的认识。
Expert Opin Drug Deliv. 2023 Mar;20(3):335-348. doi: 10.1080/17425247.2023.2175814. Epub 2023 Feb 16.
8
Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19.基于纳米材料的药物递送系统有望成为新冠肺炎患者的载体。
RSC Adv. 2021 Aug 2;11(43):26463-26480. doi: 10.1039/d1ra04835j.
9
Pharmacokinetics study of chitosan-coated liposomes containing sumatriptan in the treatment of migraine.含舒马曲坦的壳聚糖包衣脂质体治疗偏头痛的药代动力学研究。
Caspian J Intern Med. 2022 Winter;13(1):90-99. doi: 10.22088/cjim.13.1.90.
10
Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines.延长吸入药物肺部暴露的药物策略。
Acta Pharm Sin B. 2021 Aug;11(8):2565-2584. doi: 10.1016/j.apsb.2021.05.015. Epub 2021 May 21.